Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice.
hepatitis
in vivo gene transfection
interaction with serum components
lipofection
liver
lung
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
10 Apr 2020
10 Apr 2020
Historique:
received:
03
03
2020
revised:
04
04
2020
accepted:
09
04
2020
entrez:
16
4
2020
pubmed:
16
4
2020
medline:
16
4
2020
Statut:
epublish
Résumé
Understanding the in vivo fate of lipoplex, which is composed of cationic liposomes and DNA, is an important issue toward gene therapy. In disease conditions, the fate of lipoplex might change compared with the normal condition. Here, we examined the contribution of interaction with serum components to in vivo transfection using lipoplex in hepatitis mice. Prior to administration, lipoplex was incubated with serum or albumin. In the liver, the interaction with albumin enhanced gene expression in hepatitis mice, while in the lung, the interaction with serum or albumin enhanced it. In normal mice, the interaction with albumin did not enhance hepatic and pulmonary gene expression. Furthermore, hepatic and pulmonary gene expression levels of albumin-interacted lipoplex were correlated with serum transaminases in hepatitis mice. The albumin interaction increased the hepatic accumulation of lipoplex and serum tumor necrosis factor-α level. We suggest that the interaction with albumin enhanced the inflammation level after the administration of lipoplex in hepatitis mice. Consequently, the enhancement of the inflammation level might enhance the gene expression level. Information obtained in the current study will be valuable toward future clinical application of the lipoplex.
Identifiants
pubmed: 32290201
pii: pharmaceutics12040341
doi: 10.3390/pharmaceutics12040341
pmc: PMC7238045
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 21590165
Références
J Pharmacol Exp Ther. 2005 Nov;315(2):484-93
pubmed: 16033911
J Nutr Sci Vitaminol (Tokyo). 1998 Apr;44(2):249-55
pubmed: 9675705
J Control Release. 2019 Sep 28;310:155-187
pubmed: 31454533
J Control Release. 2017 Jan 10;245:27-40
pubmed: 27865853
Cell Mol Immunol. 2009 Oct;6(5):327-34
pubmed: 19887045
Pharmaceutics. 2019 Jan 15;11(1):
pubmed: 30650541
Toxicol Lett. 1998 Sep 1;98(1-2):115-21
pubmed: 9776568
Mol Ther. 2020 Mar 4;28(3):709-722
pubmed: 31968213
Biochim Biophys Acta. 1994 Apr 20;1191(1):43-51
pubmed: 8155683
Pharmaceutics. 2019 Nov 27;11(12):
pubmed: 31783620
J Pharmacol Toxicol Methods. 2002 Jul-Aug;48(1):41-4
pubmed: 12750040
J Pharm Sci. 2008 Aug;97(8):3074-83
pubmed: 18064709
J Liposome Res. 2009;19(2):141-7
pubmed: 19235544
Pharmaceutics. 2020 Feb 21;12(2):
pubmed: 32098191
Biol Pharm Bull. 2013;36(11):1807-13
pubmed: 24189424
J Exp Med. 1962 Jul 1;116:55-72
pubmed: 13914520
Gastroenterology. 1995 Jun;108(6):1849-54
pubmed: 7768392
J Pharm Pharm Sci. 2011;14(2):274-82
pubmed: 21733415
Hepatogastroenterology. 1990 Jun;37(3):319-23
pubmed: 2373463
Mol Cell Proteomics. 2008 Dec;7(12):2464-74
pubmed: 18678562
Toxicol Lett. 2012 Mar 7;209(2):107-12
pubmed: 22207076
Toxicol Appl Pharmacol. 1998 Nov;153(1):109-18
pubmed: 9875305
J Gene Med. 2011 Nov;13(11):632-43
pubmed: 22002583
J Infect Dis. 1995 Feb;171(2):350-5
pubmed: 7844371
Gastroenterology. 1978 May;74(5 Pt 1):859-65
pubmed: 346431
Eur J Pharm Biopharm. 2001 Sep;52(2):165-72
pubmed: 11522482
Hepatology. 2012 Jul;56(1):259-69
pubmed: 22271390
Pharmaceutics. 2020 Jan 30;12(2):
pubmed: 32019150
Cancer Res. 1948 Nov;8(11):513-8
pubmed: 18114935
Toxicol Appl Pharmacol. 1993 Apr;119(2):275-9
pubmed: 8480336
J Immunol. 1991 Jun 15;146(12):4234-41
pubmed: 2040798
Pharmaceutics. 2020 Mar 03;12(3):
pubmed: 32138146
Surg Gynecol Obstet. 1977 Jan;144(1):51-7
pubmed: 12579
Hum Gene Ther. 2000 Dec 10;11(18):2493-513
pubmed: 11119421
J Rheumatol. 1999 Sep;26(9):2018-24
pubmed: 10493685
Pharm Res. 2007 May;24(5):946-54
pubmed: 17372685
Jpn J Pharmacol. 1985 Dec;39(4):503-14
pubmed: 4094193
J Control Release. 2020 Feb;318:158-175
pubmed: 31862358
Toxicol Lett. 2001 Mar 31;120(1-3):317-21
pubmed: 11323190
Gene Ther. 2001 May;8(9):677-86
pubmed: 11406762
Int J Oncol. 1997 Sep;11(3):497-507
pubmed: 21528238
J Control Release. 2019 Aug 10;307:292-301
pubmed: 31252037
Mol Cell Biol. 1996 May;16(5):2341-9
pubmed: 8628301
Mol Ther. 2004 Oct;10(4):719-29
pubmed: 15451456
Gene Ther. 1997 Sep;4(9):950-60
pubmed: 9349432
Acta Obstet Gynecol Scand. 1953;32(3):359-67
pubmed: 13123852
Front Immunol. 2020 Jan 09;10:2945
pubmed: 31998287
Hum Gene Ther. 2001 Apr 10;12(6):685-96
pubmed: 11426467
Pharm Res. 2000 Mar;17(3):306-13
pubmed: 10801219